Cite
MLA Citation
P. Vyas et al.. “P553: A PHASE 2, OPEN-LABEL, MULTIARM, MULTICENTER STUDY TO EVALUATE MAGROLIMAB COMBINED WITH ANTILEUKEMIA THERAPIES FOR FIRST-LINE, RELAPSED/REFRACTORY, OR MAINTENANCE TREATMENT OF ACUTE MYELOID LEUKEMIA.” HemaSphere, vol. 6, n.d., pp. 452–453. http://access.bl.uk/ark:/81055/vdc_100158014008.0x00002d